67 results on '"Alcolea S"'
Search Results
2. Viral co-detection in severe bronchiolitis and lung function, allergic sensitization and asthma prevalence in school-aged children
- Author
-
Gonzalez-German, M F, primary, Ruiz-Gonzalez, S, additional, Alcolea, S, additional, Pozo, F, additional, Casas, I, additional, Calvo, C, additional, and Garcia-Garcia, M L, additional
- Published
- 2022
- Full Text
- View/download PDF
3. Comportamiento de la actividad física cotidiana en pacientes con hipertensión arterial pulmonar en tratamiento con antagonistas de los receptores de la endotelina
- Author
-
Carpio Segura, C.J., Alcolea, S., Ríos, J., García-Río, F., and Álvarez-Sala, R.
- Published
- 2012
- Full Text
- View/download PDF
4. SARS-CoV-2 in pets of infected family groups in a severely affected region in Spain
- Author
-
Mendez, A., Jiménez-Clavero, M.A., Calvo, C., Pérez-Ramírez, E., Fernández-Pinero, J., Llorente, F., Sainz, T., Aguilera-Sepúlveda, P., Alcolea, S., Escolano, L., Cano, C., Novoa, I., De la Torre, A., and Iglesias, I.
- Subjects
Microbiology (medical) ,OHEJP ,Infectious Diseases ,SARS-CoV-2 ,General Medicine ,One Health ,COVRIN - Abstract
Purpose The COVID-19 pandemic has caused an unprecedented health crisis with devastating effects. Current evidence suggests that SARS-CoV-2 could have an animal origin. Many uncertainties about the behaviour of the virus still persist, and understanding all the keys of this epidemic requires an interdisciplinary One Health approach spanning the human and animal health sectors. The closest coexistence between people and animals occurs in large cities. This study aims to identify the epidemiology (infection rate, risk habits, etc...) and evolution of the disease in pets that have coexisted during the confinement with family groups affected by the disease in areas of high population density and high disease incidence, i.e. Madrid. Methods & Materials A network of veterinary clinics was created to provide sampling points for the pets. The family groups included both health workers from the collaborating hospitals and affected pet owners informed through the network of clinics. Results Epidemiological and clinical data were collected from 60 family groups and their pets. An epidemiological questionnaire and sample collection (oral and nasal swabs, faeces and blood) were carried out on each pet. The samples were analyzed by RRT-PCR and ELISA. Of the 55 pets analysed (17 cats and 38 dogs), 5 cats presented antibodies. This seroprevalence is in agreement with that shown by Patterson et al, 2020 in cats in Italy in highly affected areas. Conclusion This study intends to extend the knowledge of the epidemiology and evolution of the disease in pets.
- Published
- 2022
5. Hipertensión arterial pulmonar en paciente con neumonía intersticial no específica y con test de vasorreactividad positivo
- Author
-
Carpio, C., Alcolea, S., Ríos, J.J., Gómez-Carrera, L., Bonilla, G., and Álvarez-Sala, R.
- Published
- 2011
- Full Text
- View/download PDF
6. SARS-CoV-2 in pets of infected family groups in a severely affected region in Spain
- Author
-
Mendez, A., primary, Jiménez-Clavero, M.A., additional, Calvo, C., additional, Pérez-Ramírez, E., additional, Fernández-Pinero, J., additional, Llorente, F., additional, Sainz, T., additional, Aguilera-Sepúlveda, P., additional, Alcolea, S., additional, Escolano, L., additional, Cano, C., additional, Novoa, I., additional, De la Torre, A., additional, and Iglesias, I., additional
- Published
- 2022
- Full Text
- View/download PDF
7. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study
- Author
-
Luque-Paz, David, Tattevin, Pierre, Loubet, Paul, Bénézit, François, Thibault, Vincent, Lainé, Fabrice, Vanhems, Philippe, Amour, Selilah, Lina, Bruno, Duval, Xavier, L’honneur, Anne-Sophie, Fidouh, Nadhira, Vallejo, Christine, Alain, Sophie, Galtier, Florence, Foulongne, Vincent, Lagathu, Gisèle, Lenzi, Nezha, Lesieur, Zineb, Launay, Odile, Jouneau, Stéphane, Loulergue, P., Momcilovic, S., Mira, J., Marin, N., Charpentier, J., Regent, A., Kanaan, R., Dumas, F., Doumenc, B., Lachatre, M., Szwebel, T., Kansao, J., Costa, Y., Alexandra, J., Becheur, H., Belghalem, K., Bernard, J., Bleibtreu, A., Boisseau, M., Bories, R., Brugiere, O., Brunet, F., Burdet, C., Casalino, E., Caseris, M., Chansiaux, C., Chauchard, M., Chavance, P., Choquet, C., Cloppet-Fontaine, A., Colosi, L., Couset, B., Crestani, B., Crocket, F., Debit, A., Delanoe, K, Descamps, V., Dieude, P., Dossier, A., Douron, N., Dupeyrat, E., Emeyrat, N., Fernet, C., Goulenok, T., Harent, S., Jouenne, R., Justet, A., Leleu, A., Lerat, I., Lilamand, M., Mal, H., Marceau, A., Metivier, A.-C., Oplelatora, K., Papo, T., Pelletier, A.-L., Pereira, L., Pradere, P., Prommier, R, Ralainnazava, P., Ranaivoision, M., Raynaud-Simon, A., Rioux, C., Sacre, K., Verry, V., Vuong, V., Yazdapanah, Y., Houhou, N., Géraud, P., Driss, V., Maugueret, V., Crantelle, L., Agostini, C., Ray, M., Letois, F., Mura, T., Serrand, C., Noslier, S., Giordano, A., Chevassus, H., Nyiramigisha, E., Merle, C., Bourdin, A., Konaté, A., Capdevilla, X., Du Cailar, G., Terminet, A., Blain, H., Leglise, M., Le Quellec, A., Corne, P., Landreau, L., Klouche, K., Bourgeois, A., Sebbane, M., Mourad, G., Leray, H., Postil, D., Alcolea, S., Couve-Deacon, E., Rogez, S., Argaud, L., Cour, M., Hernu, R., Simon, M., Baudry, T., Tazarourte, K., Bui-Xuan, C., Fattoum, J., Valette, M., Rochas, S., Cochennec, S., Thébault, E., Revest, M., Sébillotte, M., Le Bot, A., Baldeyrou, M., Patrat-Delon, S., Cailleaux, M., Pronier, C., CHU Pontchaillou [Rennes], ARN régulateurs bactériens et médecine (BRM), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Virulence Bactérienne et Infections Chroniques (VBIC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Hospices Civils de Lyon (HCL), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre d'Investigation Clinique de Limoges (CIC1435), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM), Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), CIC Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), CIC Cochin Pasteur (CIC 1417), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu-Groupe hospitalier Broca-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), and This work was not funded. The study sites received funding from Sanofi Pasteur and MSD for the FLUVAC study. Vaccine producers had no role in the study design, data analysis, decision to publish or preparation of the manuscript.
- Subjects
Adult ,Multidisciplinary ,[SDV]Life Sciences [q-bio] ,Respiratory Syncytial Virus Infections ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Adrenal Cortex Hormones ,Virus Diseases ,Respiratory Syncytial Virus, Human ,Influenza, Human ,Viruses ,Humans ,Prospective Studies ,Respiratory Tract Infections - Abstract
Inhaled corticosteroids (ICS) have been associated with increased risk of pneumonia. Their impact on respiratory virus infections is unclear. We performed a post-hoc analysis of the FLUVAC cohort, a multicenter prospective cohort study of adults hospitalized with influenza-like illness (ILI) during six consecutive influenza seasons (2012–2018). All patients were tested for respiratory virus infection by multiplex PCR on nasopharyngeal swabs and/or bronchoalveolar lavage. Risk factors were identified by logistic regression analysis. Among the 2658 patients included, 537 (20.2%) were treated with ICS before admission, of whom 282 (52.5%, 282/537) tested positive for at least one respiratory virus. Patients on ICS were more likely to test positive for non-influenza respiratory viruses (25.1% vs. 19.5%, P = 0.004), especially for adenovirus (aOR 2.36, 95% CI 1.18–4.58), and respiratory syncytial virus (aOR 2.08, 95% CI 1.39–3.09). Complications were reported in 55.9% of patients on ICS (300/537), primarily pneumonia (171/535, 32%). Among patients on chronic ICS who tested positive for respiratory virus, 14.2% (40/282) were admitted to intensive care unit, and in-hospital mortality rate was 2.8% (8/282). Chronic use of ICS is associated with an increased risk of adenovirus or RSV infections in patients admitted for ILI.
- Published
- 2021
- Full Text
- View/download PDF
8. STUDY OF THE PREVALENCE OF RESPIRATORY ILLNESSES AND COMORBIDITY ASSOCIATED IN PATIENTS REFERRED FOR THE FIRST TIME TO A CONSULTANT OF PNEUMOLOGY: 1060
- Author
-
FERNÁNDEZ-LAHERA, J, LOSADA, T, CEPEDA, S, ALCOLEA, S, MARTÍNEZ, A, GARCÍA, C, PRADOS, C, VILLASANTE, C, and ALVAREZ-SALA, R
- Published
- 2011
9. Portopulmonary hypertension: prognosis and management in the current treatment era. Results from the REHAP Registry
- Author
-
Lázaro Salvador M, Quezada Loaiza CA, Rodríguez Padial L, Barberá JA, López-Meseguer M, López-Reyes R, Sala Llinas E, Alcolea S, Blanco I, and Escribano Subías P
- Subjects
PAH-targeted therapy, Portal hypertension, Portopulmonary hypertension, Pulmonary arterial hypertension, survival - Abstract
Portopulmonary hypertension (PoPH) is a rare condition with poorer survival compared to idiopatic/familial pulmonary arterial hypertension (IPAH/FPAH).
- Published
- 2020
10. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network
- Author
-
Rondy, M., Castilla, J., Launay, O., Costanzo, S., Ezpeleta, C., Galtier, F., de Gaetano Donati, K., Moren, A., Beristain, X., Chamorro, J., Gabari, M., Artajo, P., Lameiro, F., Barrado, L., Ortega, M., Torres, M., Garcia Irure, J. J., Irisarri, F., Garcia Cenoz, M., Guevara, M., Casado, I., Diaz, J., Martinez-Baz, I., Lenzi, N., Lesieur, Z., Bonmarin, I., Merle, C., Foulongne, V., Letois, F., Driss, V., Geraud, P., Bourdin, A., Landreau, L., Konate, A., Corne, P., Sebbane, M., Klouche, K., Leglise, M. -S., Loulergue, P., Kanaan, R., Dumas, F., Krivine, A., Moncilovic, S., Ali, N., Duval, X., Costa, Y., Ait Naman, R., Yazdapanah, Y., Caseris, M., Dournon, N., Papo, T., Dossier, A., Becheur, H., Pelletier, A. -L., Mal, M., Marceau, A., Aubier, M., Bories, R., Casalino, E., Choquet, C., Houhou, N., Vanhems, P., Regis, C., Jouneau, S., Laine, F., Tattevin, P., Beuzit, L., Thebault, E., Fey, S., Lagathu et Sophie Cha, G., Postil, D., Alcolea, S., Rogez, S., Valette, M., Lina, B., Cauda, R., Taccari, F., Santangelo, R., Perlasca, F., Fichera, G., Dara, M., Iacoviello, L., Olivieri, M., CIC - Biotherapie - AP-HP (cochin - Pasteur), Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Eloi, CIC Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi-Institut National de la Santé et de la Recherche Médicale (INSERM), Biocommunication en Cardio-Métabolique (BC2M), Université de Montpellier (UM), Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Saint Eloi (CHRU Montpellier), and Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,[SDV]Life Sciences [q-bio] ,Logistic regression ,medicine.disease_cause ,Influenza A Virus, H1N1 Subtype ,0302 clinical medicine ,Outcome Assessment, Health Care ,Influenza A virus ,Immunology and Allergy ,Medicine ,030212 general & internal medicine ,hospital ,Young adult ,media_common ,Aged, 80 and over ,Influenza vaccine ,Vaccination ,virus diseases ,Middle Aged ,Research Papers ,3. Good health ,Hospitalization ,case control studies ,Italy ,Influenza Vaccines ,Female ,France ,Seasons ,Adult ,medicine.medical_specialty ,Adolescent ,030231 tropical medicine ,Immunology ,Young Adult ,03 medical and health sciences ,Internal medicine ,Influenza, Human ,A h1n1 influenza ,Humans ,media_common.cataloged_instance ,European Union ,European union ,Intensive care medicine ,Aged ,Pharmacology ,business.industry ,Influenza A Virus, H3N2 Subtype ,Case-control study ,Influenza ,multicentre studies ,Logistic Models ,Spain ,Case-Control Studies ,business ,Sentinel Surveillance - Abstract
International audience; We conducted a multicentre test negative case control study to estimate the 2013–14 influenza vaccine effectiveness (IVE) against hospitalised laboratory confirmed influenza in 12 hospitals in France, Italy and Spain. We included all ≥18 years hospitalised patients targeted by local influenza vaccination campaign reporting an influenza-like illness within 7 days before admission. We defined as cases patients RT-PCR positive for influenza and as controls those negative for all influenza virus. We used a logistic regression to calculate IVE adjusted for country, month of onset, chronic diseases and age. We included 104 A(H1N1)pdm09, 157 A(H3N2) cases and 585 controls. The adjusted IVE was 42.8% (95%CI: 6.3;65;0) against A(H1N1)pdm09. It was respectively 61.4% (95%CI: −1.9;85.4), 39.4% (95%CI: −32.2;72.2) and 19.7% (95%CI:-148.1;74.0) among patients aged 18–64, 65–79 and ≥80 years. The adjusted IVE against A(H3N2) was 38.1% (95%CI: 8.3;58.2) overall. It was respectively 7.8% (95%CI: −145.3;65.4), 25.6% (95%CI: −36.0;59.2) and 55.2% (95%CI: 15.4;76.3) among patients aged 18–64, 65–79 and ≥80 years. These results suggest a moderate and age varying effectiveness of the 2013–14 influenza vaccine to prevent hospitalised laboratory-confirmed influenza. While vaccination remains the most effective prevention measure, developing more immunogenic influenza vaccines is needed to prevent severe outcomes among target groups. © 2016 Taylor & Francis.
- Published
- 2016
- Full Text
- View/download PDF
11. Expression of IL-1a correlates with distant metastasis in patients with head and neck squamous cell carcinoma
- Author
-
León X., Bothe C., García J., Parreño M., Alcolea S., Quer M., Vila L., and Camacho M.
- Subjects
very elderly ,von Willebrand factor ,high risk patient ,metastasis free survival ,RNA interference ,distant metastasis ,cell motion ,time factor ,middle aged ,genetics ,endothelium cell ,transendothelial and transepithelial migration ,disease free survival ,comparative study ,cancer cell ,Aged, 80 and over ,messenger RNA ,adult ,risk assessment ,gene expression regulation ,IL1A protein, human ,protein function ,aged ,female ,cytokine release ,risk factor ,Head and Neck Neoplasms ,Carcinoma, Squamous Cell ,cytokine production ,secondary ,low risk patient ,signal transduction ,oropharynx carcinoma ,capillary endothelial cell ,interleukin 8 ,head and neck squamous cell carcinoma ,Article ,male ,protein secretion ,human ,protein expression ,gelatinase A ,vasculotropin ,chemokine receptor CXCR4 ,tumor cell line ,cell adhesion ,major clinical study ,mortality ,interleukin 1alpha ,treatment outcome ,pathology ,genetic transfection ,metabolism - Abstract
The presence of IL-1 in human cancers is associated with aggressive tumor biology but its prognostic value is unknown. We studied whether IL-1a expression is a prognostic marker of distant metastasis in patients with head and neck squamous cell carcinoma (HNSCC). IL-1a mRNA and protein levels were determined in tumor samples and cancer cell lines using RT-PCR and ELISA. The effects of constitutive IL-1a expression by tumor lines were characterized. IL-1a mRNA and protein secretion were higher in tumor samples from patients who later developed distant metastasis than in patients who did not. By using distant metastasis as a dependent variable, patients were classified into two categories of IL-1a transcript-levels. The high-IL-1a group had a significantly lower five-year distant metastasis-free survival than the low-IL-1a group [70.0% (CI 95%: 55.9-84.1%) vs 94.7% (CI 95%:90.2-99.2%)]. When IL-1a transcript-levels were combined with clinical factors related to tumor metastasis, the predictive power of the model increased significantly. Additionally, transcript levels of IL-1a correlated significantly with those of the IL-1 family genes and genes related to the metastatic process. IL-1 treatment of microvascular endothelial cells increased adhesion of HNSCC cells but no differences were found based on constitutive IL-1a expression by tumor cells. Nevertheless, IL-1a produced by tumor cells effectively increased their transmigration across the endothelium. We found a significant relationship between IL-1a expression and development of distant metastasis in HNSCC patients. IL-1a expression could help to define a subset of patients at high risk of distant metastasis who could benefit from adjuvant treatment.
- Published
- 2015
- Full Text
- View/download PDF
12. Cataluña -> Andalucía, Andalucía -> Cataluña, una permanente relación artística
- Author
-
Alcolea S.
- Published
- 1997
- Full Text
- View/download PDF
13. Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy
- Author
-
Quintana A., Avilés F.X., Terra X., Alcolea S., Camacho M., Quer M., Vila L., and León X.
- Subjects
survival rate ,Adult ,Male ,genetic association ,gene overexpression ,synaptotagmin I ,cisplatin ,local failure free survival ,head and neck squamous cell carcinoma ,Real-Time Polymerase Chain Reaction ,external beam radiotherapy ,chemoradiotherapy ,cancer control ,cancer radiotherapy ,Humans ,controlled study ,human ,RNA, Messenger ,Aged ,Retrospective Studies ,Aged, 80 and over ,messenger RNA ,cancer staging ,article ,NF-kappa B ,larynx cancer ,Middle Aged ,hypopharynx cancer ,mouth cancer ,oropharynx cancer ,major clinical study ,human tissue ,immunoglobulin enhancer binding protein ,female ,priority journal ,radiosensitivity ,real time polymerase chain reaction ,Head and Neck Neoplasms ,Carcinoma, Squamous Cell ,Neoplasm Recurrence, Local - Abstract
Background The aim of this study was to evaluate nuclear factor-kappa B (NF-?B) expression as a biologic marker to predict local control in patients with head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy or chemoradiotherapy. Methods The mRNA expression levels of the NF-?B family genes were determined with real-time-polymerase chain reaction in 77 patients with HNSCC treated with radiotherapy or chemoradiotherapy. Results The mRNA NF-?B (p65) expression in pretreatment tumors was significantly related to local control (p =.03). The 5-year local recurrence-free survival rate in patients with low-level NF-?B (p65) expression (n = 42) was 79.9%, and in patients with a high level of expression it was 42.1% (p =.001). In a multivariate analysis, the mRNA NF-?B (p65) expression level was the only variable related to local control of the tumor. Conclusion Expression of the NF-?B (p65) gene may be a radiosensitivity marker for patients with a HNSCC. © 2012 Wiley Periodicals, Inc.
- Published
- 2013
14. Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk
- Author
-
Camacho M., Martinez-Perez A., Buil A., Siguero L., Alcolea S., López S., Fontcuberta J., Souto J.-C., Vila L., and Soria J.-M.
- Subjects
leukotriene C4 synthase ,cardiovascular risk ,Male ,Adolescent ,genetic association ,sex difference ,5-Lipoxygenase-Activating Proteins ,heritability ,smoking ,fatty acid blood level ,environmental factor ,Risk Factors ,Humans ,Thrombophilia ,artery thrombosis ,controlled study ,Genetic Predisposition to Disease ,human ,Child ,protein expression ,Aged ,Glutathione Transferase ,leukotriene A4 hydrolase ,Aged, 80 and over ,Epoxide Hydrolases ,arachidonate 5 lipoxygenase ,Arachidonate 5-Lipoxygenase ,quantitative analysis ,human cell ,adult ,article ,leukotriene B4 ,phenotypic variation ,Middle Aged ,arachidonate 5 lipoxygenase activating protein ,major clinical study ,genetic correlation ,human tissue ,household ,female ,Phenotype ,priority journal ,Spain ,Cardiovascular Diseases ,Child, Preschool ,idiopathic disease ,genetic trait ,genetic susceptibility - Abstract
Objective: Leukotrienes (LT) play a role in inflammation, cardiovascular diseases, and cancer. Although some studies suggest that there are genes that determine variability of some LT-related phenotypes, the genetic influence on these phenotypes has not been evaluated. Methods: The relative contributions of genetic and environmental influences to the 5-lipoxygenase pathway-related phenotypes (5-Lipoxygenase, five lipoxygenase activating protein (FLAP), LTA4-hydrolase and LTC4-synthase expression, and LTB4-plasma concentration and LTB4 production by stimulated whole blood) were assessed in a sample of 934 individuals in 35 extended families. Our design is based on extended families recruited through a probands with idiopathic thrombophilia. This strategy allows us the analysis of the effects of measured covariates (such as sex, age and smoking), genes, and environmental variables shared by members of a household. Results: All of these phenotypes showed significant genetic contributions, with heritabilities ranging from 0.33 to 0.51 for enzyme expression and from 0.25 to 0.50 for LTB4 production of the residual phenotypic variance. Significant phenotypic and genetic correlation among the LT-related traits was found. More importantly, FLAP and LTA4-hydrolase expression exhibit significant genetic correlations with arterial thrombosis, indicating that some of the genes that influence quantitative variation in these phenotypes also influence the risk of thrombosis. Conclusion: This is the first study that quantifies the genetic component of 5-Lipoxygenase pathway phenotypes. The high heritability of these traits and the significant genetic correlations between arterial thrombosis and some of these phenotypes suggest that the exploitation of correlated quantitative phenotypes will aid the search for susceptibility genes. © 2012 Elsevier Ireland Ltd.
- Published
- 2012
15. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE 2
- Author
-
Alcolea S., Antón R., Camacho M., Soler M., Alfranca A., Avilés-Jurado F.-X., Redondo J.-M., Quer M., León X., and Vila L.
- Subjects
interleukin 1beta ,cell migration ,Chemical Fractionation ,fibroblast ,angiogenesis ,Cell Movement ,prostaglandin synthase ,cyclooxygenase 1 ,endothelium cell ,cyclooxygenase 2 ,cancer cell ,Arachidonic Acid ,quantitative analysis ,messenger RNA ,prostaglandin synthesis ,apoptosis ,article ,unclassified drug ,cytokine release ,priority journal ,Head and Neck Neoplasms ,Carcinoma, Squamous Cell ,cytokine production ,cell cycle ,coculture ,signal transduction ,culture medium ,in vitro study ,high performance liquid chromatography ,phenotype ,Human Umbilical V ,interleukin 1 ,Dinoprostone ,controlled study ,prostanoid ,protein expression ,Cell Proliferation ,prostaglandin E2 ,cell culture ,nonhuman ,flow cytometry ,Fibroblasts ,thermostability ,Coculture Techniques ,prostaglandin synthase 1 ,protein analysis ,Culture Media, Conditioned ,molecular interaction ,interleukin 1alpha ,interleukin 1 receptor blocking agent ,head and neck cancer ,upregulation - Abstract
Prostaglandin (PG)E 2 is relevant in tumor biology, and interactions between tumor and stroma cells dramatically influence tumor progression. We tested the hypothesis that cross-talk between head and neck squamous cell carcinoma (HNSCC) cells and fibroblasts could substantially enhance PGE 2 biosynthesis. We observed an enhanced production of PGE 2 in cocultures of HNSCC cell lines and fibroblasts, which was consistent with an upregulation of COX-2 and microsomal PGE-synthase-1 ( mPGES-1) in fibroblasts. In cultured endothelial cells, medium from fibroblasts treated with tumor cell-conditioned medium induced in vitro angiogenesis, and in tumor cell induced migration and proliferation, these effects were sensitive to PGs inhibition. Proteomic analysis shows that tumor cells released IL-1, and tumor cell-induced COX-2 and mPGES-1 were suppressed by the IL-1-receptor antagonist. IL-1a levels were higher than those of IL-1ß in the tumor cell-conditioning medium and in the secretion from samples obtained from 20 patients with HNSCC. Fractionation of tumor cell-conditioning media indicated that tumor cells secreted mature and unprocessed forms of IL-1. Our results support the concept that tumor-associated fibroblasts are a relevant source of PGE 2 in the tumor mass. Because mPGES-1 seems to be essential for a substantial biosynthesis of PGE 2, these findings also strengthen the concept that mPGES-1 may be \a target for therapeutic intervention in patients with HNSCC. Copyright © 2012 by the American Society for Biochemistry and Molecular Biology, Inc.
- Published
- 2012
- Full Text
- View/download PDF
16. Hypoxia upregulates PGI-synthase and increases PGI2 release in human vascular cells exposed to inflammatory stimuli
- Author
-
Camacho M., Rodríguez C., Guadall A., Alcolea S., Orriols M., Escudero J.-R., Martínez-González J., and Vila L.
- Subjects
Male ,interleukin 1beta ,animal experiment ,Blotting, Western ,Interleukin-1beta ,Myocytes, Smooth Muscle ,Polymerase Chain Reaction ,fatty acid blood level ,Dinoprostone ,Muscle, Smooth, Vascular ,animal tissue ,Mice ,Animals ,Humans ,controlled study ,hypoxia inducible factor 1alpha ,endothelium cell ,human ,cyclooxygenase 2 ,Promoter Regions, Genetic ,protein expression ,mouse ,Cells, Cultured ,prostaglandin E2 ,nonhuman ,prostaglandin release ,messenger RNA ,prostacyclin ,hypoxia ,human cell ,article ,Endothelial Cells ,Epoprostenol ,Cell Hypoxia ,enzyme activity ,Mice, Inbred C57BL ,priority journal ,inflammation ,vascular smooth muscle ,Prostaglandin-Endoperoxide Synthases ,Culture Media, Conditioned ,smooth muscle fiber ,prostacyclin synthase ,upregulation - Abstract
Hypoxia affects vascular function and cell metabolism, survival, growth, and motility; these processes are partially regulated by prostanoids. We analyzed the effect of hypoxia and inflammation on key enzymes involved in prostanoid biosynthesis in human vascular cells. In human vascular smooth muscle cells (VSMC), hypoxia and interleukin (IL)-1ß synergistically increased prostaglandin (PG)I2 but not PGE2 release, thereby increasing the PGI2/PGE2 ratio. Concomitantly, these stimuli upregulated cyclooxygenase-2 (COX-2) expression (mRNA and protein) and COX activity. Interestingly, hypoxia enhanced PGI-synthase (PGIS) expression and activity in VSMC and human endothelial cells. Hypoxia did not significantly modify the inducible microsomal-PGE-synthase (mPGES)-1. Hypoxia-inducible factor (HIF)-1a-silencing abrogated hypoxia-induced PGIS upregulation. PGIS transcriptional activity was enhanced by hypoxia; however, the minimal PGIS promoter responsive to hypoxia (-131 bp) did not contain any putative hypoxia response element (HRE), suggesting that HIF-1 does not directly drive PGIS transcription. Serial deletion and site-directed mutagenesis studies suggested several transcription factors participate cooperatively. Plasma levels of the stable metabolite of PGI2 and PGIS expression in several tissues were also upregulated in mice exposed to hypoxia. These data suggest that PGIS upregulation is part of the adaptive response of vascular cells to hypoxic stress and could play a role in counteracting the deleterious effect of inflammatory stimuli. Copyright © 2011 by the American Society for Biochemistry and Molecular Biology, Inc.
- Published
- 2011
- Full Text
- View/download PDF
17. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals
- Author
-
Rondy, M., Launay, O., Puig-Barbera, J., Gefenaite, G., Castilla, J., De Gaetano Donati, Katleen, Galtier, F., Hak, E., Guevara, M., Costanzo, S., Moren, A., Lenzi, N., Lesieur, Z., Bonmarin, I., Duval, X., Costa, Y., Kanagaratnam, A., Yazdapanah, Y., Caseris, M., Dournon, N., Papo, T., Dossier, A., Becheur, H., Pelletier, A. -L., Mal, H., Marceau, A., Aubier, M., Bories, R., Casalino, E., Choquet, C., Houhou, N., Loulergue, P., Kanaan, R., Dumas, F., Postil, D., Alcolea, S., Rogez, S., Vanhaems, P., Regis, C., Merle, C., Foulongne, V., Ray, M., Maugueret-Doublet, V., Bourdin, A., Landreau, L., Konate, A., Corne, P., Sebbane, M., Klouche, K., Leglise, M. -S., Valette, M., Lina, B., Carrat, F., Chau, F., Diez-Domingo, J., Escribano-Lopez, B., Arnedo-Pena, A., Ruiz-Garcia, M., Tortajada-Girbes, M., Munuera, C. C., Sanudo, J. B., Larrea-Gonzalez, R., Gil-Guillen, V., Schwarz-Chavarri, G., Rahamat-Langendoen, J., Niesters, H., Ambrozaitis, A., Jancoriene, L., Mickiene, A., Kuliese, M., Velyvyte, D., Stolk, R. P., Zagminas, K., Ezpeleta, C., Chamorro, J., Artajo, P., Lameiro, F., Navascues, A., Ortega, M., Torres, M., Irure, J. J. G., Irisarri, F., Cenoz, M. G., Martinez-Baz, I., Cauda, Roberto, Donato, C., Santangelo, Rosaria, Perlasca, F., Fichera, Giovanni, Dara, M., Iacoviello, L., Olivieri, M., de Gaetano Donati K., Cauda R. (ORCID:0000-0002-1498-4229), Santangelo R. (ORCID:0000-0002-8056-218X), Fichera G., Rondy, M., Launay, O., Puig-Barbera, J., Gefenaite, G., Castilla, J., De Gaetano Donati, Katleen, Galtier, F., Hak, E., Guevara, M., Costanzo, S., Moren, A., Lenzi, N., Lesieur, Z., Bonmarin, I., Duval, X., Costa, Y., Kanagaratnam, A., Yazdapanah, Y., Caseris, M., Dournon, N., Papo, T., Dossier, A., Becheur, H., Pelletier, A. -L., Mal, H., Marceau, A., Aubier, M., Bories, R., Casalino, E., Choquet, C., Houhou, N., Loulergue, P., Kanaan, R., Dumas, F., Postil, D., Alcolea, S., Rogez, S., Vanhaems, P., Regis, C., Merle, C., Foulongne, V., Ray, M., Maugueret-Doublet, V., Bourdin, A., Landreau, L., Konate, A., Corne, P., Sebbane, M., Klouche, K., Leglise, M. -S., Valette, M., Lina, B., Carrat, F., Chau, F., Diez-Domingo, J., Escribano-Lopez, B., Arnedo-Pena, A., Ruiz-Garcia, M., Tortajada-Girbes, M., Munuera, C. C., Sanudo, J. B., Larrea-Gonzalez, R., Gil-Guillen, V., Schwarz-Chavarri, G., Rahamat-Langendoen, J., Niesters, H., Ambrozaitis, A., Jancoriene, L., Mickiene, A., Kuliese, M., Velyvyte, D., Stolk, R. P., Zagminas, K., Ezpeleta, C., Chamorro, J., Artajo, P., Lameiro, F., Navascues, A., Ortega, M., Torres, M., Irure, J. J. G., Irisarri, F., Cenoz, M. G., Martinez-Baz, I., Cauda, Roberto, Donato, C., Santangelo, Rosaria, Perlasca, F., Fichera, Giovanni, Dara, M., Iacoviello, L., Olivieri, M., de Gaetano Donati K., Cauda R. (ORCID:0000-0002-1498-4229), Santangelo R. (ORCID:0000-0002-8056-218X), and Fichera G.
- Abstract
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted a multicentre test-negative case–control study to estimate IVE against hospitalised laboratoryconfirmed influenza in the target population in 18 hospitals in France, Italy, Lithuania and the Navarre and Valencia regions in Spain. All hospitalised patients aged ≥18 years, belonging to the target population presenting with influenza-like illness symptom onset within seven days were swabbed. Patients positive by reverse transcription polymerase chain reaction for influenza virus were cases and those negative were controls. Using logistic regression, we calculated IVE for each influenza virus subtype and adjusted it for month of symptom onset, study site, age and chronic conditions. Of the 1,972 patients included, 116 were positive for influenza A(H1N1)pdm09, 58 for A(H3N2) and 232 for influenza B. Adjusted IVE was 21.3% (95% confidence interval (CI): -25.2 to 50.6; n=1,628), 61.8% (95% CI: 26.8 to 80.0; n=557) and 43.1% (95% CI: 21.2 to 58.9; n=1,526) against influenza A(H1N1) pdm09, A(H3N2) and B respectively. Our results suggest that the 2012/13 IVE was moderate against influenza A(H3N2) and B and low against influenza A(H1N1) pdm09.
- Published
- 2015
18. Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease
- Author
-
Fernández-Lahera, J., primary, Romera, D., additional, Gómez Mendieta, A., additional, Martínez Verdasco, A., additional, Fernández-Bujarrabal, J., additional, Santiago, A., additional, Alcolea, S., additional, Martínez-Abad, Y., additional, Prados, C., additional, Villasante, C., additional, and Alvarez-Sala, R., additional
- Published
- 2015
- Full Text
- View/download PDF
19. Protocolo diagnóstico de la disnea crónica
- Author
-
Bravo, L., Alcolea, S., and Álvarez-Sala, R.
- Published
- 2010
- Full Text
- View/download PDF
20. Effect of the number of layers of graphene on the electrical properties of TPU polymers
- Author
-
Galindo, B, primary, Alcolea, S Gil, additional, Gómez, J, additional, Navas, A, additional, Murguialday, A Ortega, additional, Fernandez, M Pérez, additional, and Puelles, R C, additional
- Published
- 2014
- Full Text
- View/download PDF
21. Seric biomarkers, right ventricle repercusion and haemodinamic instability in patients with acute severe thromboembolic desease
- Author
-
Jareno, J., primary, de Miguel, J., additional, Izquierdo, M., additional, Zamarro, C., additional, Nieto, A., additional, Lopez, E., additional, Molero, E., additional, Gutierrez, C., additional, and Alcolea, S., additional
- Published
- 2013
- Full Text
- View/download PDF
22. Cryptogenic Organizing Pneumonia and Mediastinal Lymphadenopathy
- Author
-
Alcolea, S., primary, Santiago Recuerda, A., additional, and Prado, M.C., additional
- Published
- 2004
- Full Text
- View/download PDF
23. Neumonía organizada criptogenética y adenopatías mediastínicas
- Author
-
Alcolea, S., primary, Santiago Recuerda, A., additional, and Prados, M.C., additional
- Published
- 2004
- Full Text
- View/download PDF
24. Seric biomarkers, right ventricle repercusion and haemodinamic instability in patients with acute severe thromboembolic desease.
- Author
-
Anonymous, de Miguel, J., Izquierdo, M., Zamarro, C., Nieto, A., Lopez, E., Molero, E., Gutierrez, C., and Alcolea, S.
- Published
- 2013
- Full Text
- View/download PDF
25. Zoonosis screening in Spanish immunocompromised children and their pets.
- Author
-
Garcia-Sanchez P, Romero-Trancón D, Falces-Romero I, Navarro Carrera P, Ruiz-Carrascoso G, Carmena D, Casares Jiménez M, Rivero-Juárez A, Moya L, Rodón J, Esperón F, Pérez-Hernando B, Sánchez-León R, Hurtado-Gallego J, Alcolea S, Sainz T, Calvo C, and Méndez-Echevarría A
- Abstract
Introduction: Although pets provide several social-emotional benefits for children, the risk of zoonosis must be considered among immunocompromised individuals., Methods: A prospective study was conducted in a tertiary hospital including immunocompromised patients younger than 20 years owning dogs and/or cats. Colonization and/or infection was evaluated by stool studies, bacterial swabs, blood polymerase chain reaction and serological studies in both patients and their pets, to evaluate potential zoonotic transmission occurrence., Results: We included 74 patients and their 92 pets (63 dogs, 29 cats). Up to 44.6% of the patients and 31.5% of the pets had at least 1 positive result. Up to 18.4% of pets' fecal samples were positive (bacteria, parasites or hepatitis E virus). No helminths were observed despite the high frequency of incorrect intestinal deworming practices. Among children, gastrointestinal microorganisms were found in 37.3% (primarily Clostridium difficile ). Colonization by Staphylococcus pseudintermedius was common among pets (8.0%) but not among children (0.0%). No shared colonization between owners and pets was observed, except in one case ( Blastocystis in both patient and pet feces). Among patients, serologies were positive for Strongyloides stercoralis (14.8%), Toxocara canis (3.2%), Bartonella henselae (19.1%) and hepatitis E (5.6%). Serology was positive for Rickettsia spp. (22.6%) and Babesia spp. (6.5%) in dogs and for Leishmania spp. (14.3%) and Toxoplasma spp. (14.3%) in cats., Conclusion: Exposure to zoonotic agents was detected in both patients and pets; however, shared colonization events were almost nonexistent. In our cohort, dogs and cats do not appear to entail high zoonosis transmission risk for immunocompromised patients., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Garcia-Sanchez, Romero-Trancón, Falces-Romero, Navarro Carrera, Ruiz-Carrascoso, Carmena, Casares Jiménez, Rivero-Juárez, Moya, Rodón, Esperón, Pérez-Hernando, Sánchez-León, Hurtado-Gallego, Alcolea, Sainz, Calvo and Méndez-Echevarría.)
- Published
- 2024
- Full Text
- View/download PDF
26. Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?
- Author
-
Cabrera-Rubio R, Calvo C, Alcolea S, Bergia M, Atucha J, Pozo F, Casas I, Arroyas M, Collado MC, and García-García ML
- Subjects
- Humans, Infant, Male, Female, Prospective Studies, RNA, Ribosomal, 16S genetics, Bacteria classification, Bacteria isolation & purification, Bacteria genetics, Infant, Newborn, Feces microbiology, Feces virology, Microbiota, Hospitalization, Respiratory System microbiology, Respiratory System virology, Nasopharynx microbiology, Nasopharynx virology, Severity of Illness Index, Bronchiolitis microbiology, Bronchiolitis virology, Gastrointestinal Microbiome, Respiratory Syncytial Virus Infections microbiology, Respiratory Syncytial Virus Infections virology
- Abstract
Growing evidence indicates that gut and respiratory microbiota have a potential key effect on bronchiolitis, mainly caused by respiratory syncytial virus (RSV). This was a prospective study of 96 infants comparing infants with bronchiolitis ( n = 57, both RSV and non-RSV associated) to a control group ( n = 39). Gut (feces) and respiratory [nasopharyngeal aspirate (NPA)] microbial profiles were analyzed by 16S rRNA amplicon sequencing, and respiratory viruses were identified by PCR. Clinical data of the acute episode and follow-up during the first year after infection were recorded. Pairwise comparisons showed significant differences in the gut ( R
2 = 0.0639, P = 0.006) and NPA ( R2 = 0.0803, P = 0.006) microbiota between cases and controls. A significantly lower gut microbial richness and an increase in the NPA microbial diversity (mainly due to an increase in Haemophilus , Streptococcus, and Neisseria ) were observed in the infants with bronchiolitis, in those with the most severe symptoms, and in those who subsequently developed recurrent wheezing episodes after discharge. In NPA, the higher microbial richness differed significantly between the control group and the non-RSV bronchiolitis group ( P = 0.01) and between the control group and the RSV bronchiolitis group ( P = 0.001). In the gut, the richness differed significantly between the control group and the non-RSV group ( P = 0.01) and between the control group and the RSV bronchiolitis group ( P = 0.001), with higher diversity in the RSV group. A distinct respiratory and intestinal microbial pattern was observed in infants with bronchiolitis compared with controls. The presence of RSV was a main factor for dysbiosis. Lower gut microbial richness and increased respiratory microbial diversity were associated with respiratory morbidity during follow-up., Importance: Both the intestinal and respiratory microbiota of children with bronchiolitis, especially those with respiratory syncytial virus infection, are altered and differ from that of healthy children. The microbiota pattern in the acute episode could identify those children who will later have other respiratory episodes in the first year of life. Preventive measures could be adopted for this group of infants., Competing Interests: The authors declare no conflict of interest.- Published
- 2024
- Full Text
- View/download PDF
27. Percutaneous pulmonary thrombectomy with aspiration catheters in patients with high-risk pulmonary embolism and absolute contraindication to systemic thrombolysis.
- Author
-
Tébar D, Jurado-Román A, Jiménez-Valero S, Galeote G, Gonzálvez A, Rivero B, García A, Añón Elizalde JM, Lorenzo A, Fernández Capitán C, Torres R, Soto C, Alcolea S, Rosillo S, Caro Codón J, Arbas E, Tejera F, Plaza I, Boscá L, and Moreno R
- Abstract
Background: High-risk Pulmonary Embolism (PE) mortality remains very high. Systemic thrombolysis is effective but carries significant complications and contraindications related to the hemorrhagic risk. Percutaneous thrombectomy using aspiration catheters may be an alternative in patients with a high bleeding risk., Objective: This study aimed to evaluate the results of catheter-directed thrombectomy using aspiration dedicated catheters in patients with high-risk PE and absolute contraindication to systemic thrombolysis, with specific focus on procedural success, safety, and in-hospital outcomes., Methods: A prospective study enrolled all consecutive patients diagnosed with high-risk pulmonary embolism and absolute contraindication to systemic thrombolysis, who underwent percutaneous pulmonary thrombectomy using dedicated aspiration catheters. The study documented the effectiveness and complications of the procedure, as well as patient outcomes at discharge and during the follow-up period., Results: Thirteen patients underwent percutaneous pulmonary thrombectomy using aspiration dedicated catheters. The procedure was successful for all patients, resulting in hemodynamic and respiratory improvement within the first 24 h. No deaths attributable to cardiovascular or respiratory causes occurred during admission or follow-up. Furthermore, no serious adverse events or complications were reported during the procedure or hospitalization., Conclusions: Percutaneous pulmonary thrombectomy with dedicated aspiration catheters in patients with high-risk pulmonary embolism and contraindications to systemic thrombolysis was associated with excellent clinical results and low rate of complications., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Phylogenetic evidence suggests the non-validity of the Iberian land snail genus Tartessiberus and confirms its synonymy with Iberus (Helicidae).
- Author
-
Jowers MJ, Liétor J, Tudela AR, Jódar PA, Galán-Luque I, and Moreno-Rueda G
- Abstract
The monospecific genus Tartessiberus was described in the year 2021 including a single species ( T.cilbanus ). However, its description relied solely on morphological and anatomical data. In the present work, we use a fraction of the mitochondrial DNA cytochrome oxidase subunit I (COI), 16S ribosomal RNA (16S rRNA) and the nuclear large ribosomal subunit (LSU) to clarify its validity through phylogenetic positioning. Knowledge of the distribution of this species is also improved by citing new locations and expanding the geographical range to approximately 200 km
2 . Additionally, a morphometric analysis of 259 shells is presented for comparisons with shells of the Iberusmarmoratus complex and testing the power of conchological features as a tool for specimen identification. The relatively high conchological variability found for T.cilbanus , together with the discovery of populations with intermediate conchological features between T.cilbanus and other closely related taxa, suggest that the determination of this species should be based on genetic criteria. Our molecular analyses demonstrate that T.cilbanus belongs to the Iberus genus, and thus, we proceed to update its taxonomic status to Iberuscilbanus comb. nov. , and, thus, to consider Tartessiberus from now on as a junior synonym of Iberus ., Competing Interests: The authors have declared that no competing interests exist., (Michael J. Jowers, José Liétor, Antonio R. Tudela, Pedro A. Jódar, Inés Galán-Luque, Gregorio Moreno-Rueda.)- Published
- 2024
- Full Text
- View/download PDF
29. The role of veterinarians in zoonosis prevention: Advising families of immunocompromised children with pets.
- Author
-
Garcia-Sanchez P, Romero-Trancón D, Sainz T, Calvo C, Iglesias I, Perez-Hernando B, Hurtado-Gallego J, Sánchez R, Alcolea S, Moya L, and Mendez-Echevarria A
- Abstract
Background: Pet ownership is widespread, offering numerous benefits to individuals and families. However, the risk of zoonotic diseases must be carefully considered, especially for immunosuppressed patients. Knowledge gaps in preventive measures for zoonoses have been identified, underscoring the vital role of veterinarians in addressing this issue., Objectives: This study aimed to assess the knowledge and recommendations of veterinarians regarding pet ownership by immunocompromised individuals. Additionally, we compared these insights with responses from European healthcare professionals specializing in pediatric transplant recipients., Methods: We conducted an observational, cross-sectional study involving small animal veterinarians in Spain. An online survey was administered to gather information on veterinarians' knowledge of zoonoses and their recommendations for immunocompromised pet owners., Results: A survey of 514 individuals was collected from experienced veterinarians mainly working in primary care clinics. Surprisingly, 63% of respondents did not routinely inquire about the presence of immunocompromised individuals among pet owners, although 54% offered specific recommendations for this group. Most respondents adhered to deworming guidelines for pets owned by immunocompromised individuals and demonstrated sound practices in Leishmania and Leptospira prevention, as well as the avoidance of raw food. However, gaps were noted concerning Bordetella bronchiseptica vaccination. Notably, veterinarians outperformed medical professionals in their knowledge of zoonotic cases and identification of zoonotic microorganisms. The presence of specific recommendations in veterinary clinics was viewed positively by nearly all respondents., Conclusions: Our findings indicate that veterinarians possess a superior understanding of zoonotic pathogens and exhibit greater proficiency in diagnosing zoonoses compared with physicians. They stay well-informed about recommendations outlined in established guidelines and are more likely to provide written recommendations in their clinics than physicians. Nevertheless, knowledge gaps among veterinarians emphasize the need for enhanced communication between medical and veterinary professionals. Reinforcing the "One Health" concept is imperative, with veterinarians playing a pivotal role in this collaborative effort., Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this paper., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
30. Antibiotic Utilization in Hospitalized Children with Bronchiolitis: A Prospective Study Investigating Clinical and Epidemiological Characteristics at a Secondary Hospital in Madrid (2004-2022).
- Author
-
García-García ML, Alcolea S, Alonso-López P, Martín-Martín C, Tena-García G, Casas I, Pozo F, Méndez-Echevarría A, Hurtado-Gallego J, and Calvo C
- Abstract
Bronchiolitis is a viral respiratory infection, with respiratory syncytial virus (RSV) being the most frequent agent, requiring hospitalization in 1% of affected children. However, there continues to be a noteworthy incidence of antibiotic prescription in this setting, further exacerbating the global issue of antibiotic resistance. This study, conducted at Severo Ochoa Hospital in Madrid, Spain, focused on antibiotic usage in children under 2 years of age who were hospitalized for bronchiolitis between 2004 and 2022. In that time, 5438 children were admitted with acute respiratory infection, and 1715 infants (31.5%) with acute bronchiolitis were included. In total, 1470 (87%) had a positive viral identification (66% RSV, 32% HRV). Initially, antibiotics were prescribed to 13.4% of infants, but this percentage decreased to 7% during the COVID-19 pandemic thanks to adherence to guidelines and the implementation of rapid and precise viral diagnostic methods in the hospital. HBoV- and HAdV-infected children and those with viral coinfections were more likely to receive antibiotics in the univariate analysis. A multivariate logistic regression analysis revealed a statistically independent association between antibiotic prescription and fever > 38 °C ( p < 0.001), abnormal chest-X ray ( p < 0.001), ICU admission ( p = 0.015), and serum CRP ( p < 0.001). In conclusion, following guidelines and the availability of rapid and reliable viral diagnostic methods dramatically reduces the unnecessary use of antibiotics in infants with severe bronchiolitis.
- Published
- 2023
- Full Text
- View/download PDF
31. Surveillance of Viral Respiratory Infections in the Neonatal Intensive Care Unit-Evolution in the Last 5 Years.
- Author
-
Bravo-Queipo-de-Llano B, Sánchez García L, Casas I, Pozo F, La Banda L, Alcolea S, Atucha J, Sánchez-León R, Pellicer A, and Calvo C
- Abstract
Viral respiratory infections (VRIs) in very low birthweight infants can be associated with high rates of morbidity. The COVID-19 pandemic has exerted a strong impact on viral circulation. The purpose of this study is to report on VRIs during NICU admission in infants below 32 weeks' gestation and compare data collected between the pre-and post-COVID-19 pandemic periods. A prospective surveillance study was conducted at a tertiary NICU between April 2016 and June 2022. The COVID-19 post-pandemic period was established as being from March 2020 onwards. Respiratory virus detection was performed by real-time multiplex PCR assays in nasopharyngeal aspirates (NPAs). A total of 366 infants were enrolled. There were no statistical differences between periods regarding infants' birth weight, gestational age, gender distribution, or rates of bronchopulmonary dysplasia. Among the 1589 NPA collected during the pre-COVID-19 period, 8.9% were positive, and among the 1147 NPA collected during the post-pandemic period, only 3% were positive ( p < 0.005). The type of viruses detected did not differ according to the study period (pre-COVID19 vs. post-COVID-19): rhinovirus (49.5% vs. 37.5%), adenovirus (22.6% vs. 25%), and human coronavirus (12.9% vs. 16.7%). SARS-CoV-2 was only detected in one patient. In conclusion, the viral profile causing VRI during the pre-COVID-19 and post-COVID-19 era was similar. However, the total number of VRI dropped significantly, most probably due to the global increase in infection prevention measures.
- Published
- 2023
- Full Text
- View/download PDF
32. Balancing the Risks and Benefits of Pet Ownership in Pediatric Transplant Recipients.
- Author
-
García Sánchez P, Iglesias I, Falces-Romero I, Serrano-Villar M, Calvo C, Alcolea S, Sainz T, and Mendez-Echevarría A
- Subjects
- Animals, Humans, Ownership, Quality of Life, Zoonoses epidemiology, Risk Assessment, Pets psychology, Transplant Recipients
- Abstract
In recent decades, the number of pediatric transplantations and their survival rates have increased. Psychological problems and poorer quality of life are notable among children undergoing transplantation and can have long-lasting consequences and affect immunosuppressive therapy adherence. Pet ownership and animal contact have been associated with physical, mental, and social health benefits. Despite these potential benefits, however, companion animals are known to be a source of infection, which is one of the main concerns for clinicians. Because of immunosuppression, these children are particularly vulnerable to infections. Zoonoses comprise a long list of infectious diseases and represent a major public health problem. Nevertheless, many families and most healthcare providers are unaware of these potential risks, and there is a worrisome lack of recommendations to manage the risk-benefit balance, which could pose a risk for acquiring a zoonosis. Furthermore, no data are available on the number of transplanted patients with pets, and this risk-benefit balance is difficult to adequately evaluate. In this document, we review the currently available evidence regarding the epidemiology of zoonotic infections in patients undergoing transplantation, focusing on pediatric patients from a risk-benefit perspective, to help inform decision-making for clinicians. Families and healthcare professionals should be aware of the risks, and clinicians should actively screen for pets and offer comprehensive information as part of routine clinical practice. A multidisciplinary approach will ensure proper care of patients and pets and will establish preventive measures to ensure patients are safe living with their pets., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Torque Teno Virus in Nasopharyngeal Aspirate of Children With Viral Respiratory Infections.
- Author
-
Del Rosal T, García-García ML, Casas I, Iglesias-Caballero M, Pozo F, Alcolea S, Bravo B, Rodrigo-Muñoz JM, Del Pozo V, and Calvo C
- Subjects
- Child, Preschool, Humans, DNA, Viral genetics, Filaggrin Proteins, Prospective Studies, Viral Load, DNA Virus Infections epidemiology, Pneumonia complications, Respiratory Tract Infections complications, Torque teno virus genetics, Virus Diseases complications
- Abstract
Background: Torque teno virus (TTV) is a ubiquitous anellovirus responsible for persistent infections and is considered a marker of immune function. The role of TTV as a facilitator of respiratory infections (RIs) is unknown., Objectives: Our aim was to estimate, in a prospective study, the prevalence of TTV in the nasopharyngeal aspirate (NPA) of hospitalized children <5 years old, with RIs and correlate them with outcomes and immune response., Patients and Methods: NPA was taken for testing of 16 respiratory viruses by reverse transcription-polymerase chain reaction (PCR), TTV PCR, and immunologic study., Results: Sixty hospitalized children with an RI were included. A total of 51/60 patients had positive common respiratory viral (CRV) identification. A total of 23/60 (38.3%) children were TTV+ in NPA. TTV+ patients had other CRVs in 100% of cases versus 78.3% in TTV- ( P = 0.029). The TTV+ patients tended to be older, have fever, and to need pediatric intensive care unit admission more often than TTV- patients. Abnormal chest radiograph was more frequent in the TTV+ patients, odds ratios 2.6 (95% CI: 1.3-5.2). The genetic expression of filaggrin (involved in epithelial barrier integrity) was lower in TTV+ patients; however, the levels of filaggrin in the NPA were increased., Conclusions: TTV infection is common in children with RI and could be associated with abnormal imaging in radiograph, greater severity and an alteration in filaggrin gene expression and protein release., Competing Interests: There are no conflicts of interest., (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2023
- Full Text
- View/download PDF
34. Filaggrin and cytokines in respiratory samples of preterm infants at risk for respiratory viral infection.
- Author
-
Rodrigo-Muñoz JM, Sastre B, Sánchez-García L, García-García ML, Gonzalez-Carrasco E, Fabra C, Gil-Martínez M, Lorente-Sorolla C, García-Latorre R, Alcolea S, Casas I, Calvo C, and Del Pozo V
- Subjects
- Humans, Infant, Newborn, Infant, Premature, Intensive Care Units, Neonatal, Cytokines metabolism, Virus Diseases metabolism, Filaggrin Proteins metabolism, Respiratory Tract Diseases virology
- Abstract
Respiratory viral infections (RVIs) are frequent in preterm infants possibly inducing long-term impact on respiratory morbidity. Immune response and respiratory barriers are key defense elements against viral insults in premature infants admitted to Neonatal Intensive Care Units (NICUs). Our main goals were to describe the local immune response in respiratory secretions of preterm infants with RVIs during NICU admission and to evaluate the expression and synthesis of lung barrier regulators, both in respiratory samples and in vitro models. Samples from preterm infants that went on to develop RVIs had lower filaggrin gene and protein levels at a cellular level were compared to never-infected neonates (controls). Filaggrin, MIP-1α/CCL3 and MCP-1 levels were higher in pre-infection supernatants compared to controls. Filaggrin, HIF-1α, VEGF, RANTES/CCL5, IL-17A, IL-1β, MIP-1α and MIP-1β/CCL5 levels were higher during and after infection. ROC curve and logistic regression analysis shows that these molecules could be used as infection risk biomarkers. Small airway epithelial cells stimulated by poly:IC presented reduced filaggrin gene expression and increased levels in supernatant. We conclude that filaggrin gene and protein dysregulation is a risk factor of RVI in newborns admitted at the NICU., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
35. SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid.
- Author
-
Berzosa Sánchez A, Epalza C, Navarro ML, Alcolea S, Escosa García L, Guillén Martín S, Illán Ramos M, Prieto Tato LM, Carrasco I, Sainz T, and Ramos Amador JT
- Subjects
- Adolescent, Anti-Retroviral Agents therapeutic use, Child, Humans, SARS-CoV-2, COVID-19 epidemiology, HIV Infections complications, HIV Infections epidemiology
- Abstract
Multicenter study designed to describe epidemiologic and clinical characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive cases registered among children and adolescents living with HIV (CALWH). SARS-CoV-2 infection was confirmed in 13.3% of CALWH, with all patients presenting mild symptoms, and the outcome was good in all patients. None of the HIV- and antiretroviral treatment-related variables studied were associated with greater infection risk or could be considered protective., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
36. Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population.
- Author
-
Méndez-Echevarría A, Sainz T, Falces-Romero I, de Felipe B, Escolano L, Alcolea S, Pertiñez L, Neth O, and Calvo C
- Abstract
Background: Antibody dynamics over time after SARS-CoV-2 infection are still unclear, and data regarding children are scarce., Methods: A prospective cohort study was performed including children infected by SARS-CoV-2 between March and May 2020. Patients were categorized into 3 groups: children admitted with COVID-19; outpatient children with mild COVID-19; and seropositive children participating in a seroprevalence study among cohabitants of infected healthcare workers (HCWs). Six months after the infection, a new serological control was performed., Results: A total of 58 children were included, 50% male (median age 8.3 [IQR 2.8-13.5] years). The median time between the two serological studies was 186 (IQR 176-192) days, and 86% (48/56) of the children maintained positive IgG six months after the infection. This percentage was 100% in admitted patients and 78% among the rest of the included children ( p = 0.022). The diagnoses of lower respiratory tract infection and multisystemic inflammatory syndrome were associated with persistence of IgG ( p = 0.035). The children of HCWs in the seroprevalence study lost antibodies more often ( p = 0.017). Initial IgG titers of the children who remained positive six months after the infection were significantly higher ( p = 0.008)., Conclusions: Most children infected by SARS-CoV-2 maintain a positive serological response six months after the infection. Those children who lost their IgG titer were more frequently asymptomatic or mildly symptomatic, presenting with low antibody titers after the infection.
- Published
- 2021
- Full Text
- View/download PDF
37. High Rates of SARS-CoV-2 Family Transmission in Children of Healthcare Workers During the First Pandemic Wave in Madrid, Spain: Serologic Study.
- Author
-
Méndez-Echevarría A, Sainz T, de Felipe B, Alcolea S, Olbrich P, Goycochea-Valdivia WA, Escosa-García L, Cobo L, Calvo C, and Neth O
- Subjects
- Adolescent, Antibodies, Viral blood, Asymptomatic Infections epidemiology, COVID-19 diagnosis, COVID-19 epidemiology, Child, Child, Preschool, Cross-Sectional Studies, Disease Transmission, Infectious, Family, Female, Humans, Immunoglobulin G blood, Infectious Disease Transmission, Patient-to-Professional, Male, Pandemics, SARS-CoV-2 isolation & purification, Seroconversion, Spain epidemiology, Tertiary Care Centers, COVID-19 transmission, Health Personnel
- Abstract
Background: Data on SARS-CoV-2 transmission among children living with healthcare workers (HCWs) are scarce., Methods: A cross-sectional study was performed at a tertiary Hospital in Madrid, including children of HCW who suffered from SARS-CoV-2 infection between March and May 2020. Children underwent enzyme-linked immunosorbent serological study for detecting SARS-CoV-2 antibodies: VIRCELL IgG assay., Results: One hundred thirteen children from 69 HCWs with confirmed SARS-CoV-2 infection were recruited: 47 children had positive IgG (41.6%). Children secondary attack rate was 43.7% (25% if both parents have had asymptomatic infection; 39.5% if one parent was symptomatic; and 47% when both parents had symptoms). Having a positive sibling was associated with a positive IgG result (odds ratio = 12.2; 95% confidence interval: 4.4-33.7, P < 0.001). Median age was higher in IgG positive children (P = 0.022). Children who referred anosmia presented higher IgG titles (P < 0.04)., Conclusions: We observed a very high SARS-CoV-2 transmission in children of HCW during the first pandemic wave, especially when both parents were symptomatic. Having a positive sibling was associated with seroconversion, supporting the important role of family clusters in the transmission of SARS-CoV-2., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
38. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
- Author
-
Lazaro Salvador M, Quezada Loaiza CA, Rodríguez Padial L, Barberá JA, López-Meseguer M, López-Reyes R, Sala-Llinas E, Alcolea S, Blanco I, and Escribano-Subías P
- Subjects
- Humans, Male, Prognosis, Registries, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary epidemiology, Hypertension, Pulmonary therapy, Liver Diseases, Pulmonary Arterial Hypertension
- Abstract
Background: Portopulmonary hypertension (PoPH) is a rare condition with poorer survival compared to idiopathic/familial pulmonary arterial hypertension (IPAH/FPAH)., Aims: To compare the characteristics, survival, prognostic factors and management of PoPH and IPAH/FPAH patients and to assess the impact of treatment on survival of PoPH patients., Methods: Analysis of data of prevalent and incident PoPH patients enrolled in the Spanish registry of PAH (REHAP) from January 1998 to December 2017 and comparison with IPAH/FPAH patients. Variables analysed: patient and disease (PAH and liver) characteristics, first-line PAH-targeted therapy, causes of death, prognostic factors and survival (according to aetiology and treatment in PoPH patients)., Results: Compared to IPAH/FPAH patients (n = 678), patients with PoPH (n = 237) were predominantly men, older and had better functional class and higher prevalence of ascites. Haemodynamics were better. Biomarkers for heart failure were worse. Age- and sex-adjusted 5-year survival rate from diagnosis was 49.3% for PoPH patients and 68.7% for IPAH patients (P < 0.001). Treated PoPH had better survival than non-treated. PAH- and liver-related causes accounted for 30.2% and 24.7% of deaths in PoPH patients. PoPH patients were less likely to receive first-line PAH-targeted therapy and this was associated with greater mortality. Increasing age, worse exercise capacity and ascites were independent prognostic factors of poorer survival; first-line oral monotherapy was associated with improved survival. Eight (3.4%) PoPH patients underwent liver transplantation., Conclusions: PoPH patients are undertreated and show poorer survival than IPAH/FPAH patients. First-line treatment with PAH-targeted therapy was associated with better survival. Presence of ascites was a predictor of mortality., (© 2020 Royal Australasian College of Physicians.)
- Published
- 2021
- Full Text
- View/download PDF
39. A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses.
- Author
-
Calvo C, Alcolea S, Casas I, Pozo F, Iglesias M, Gonzalez-Esguevillas M, and Luz García-García M
- Subjects
- Adolescent, Age Distribution, Betacoronavirus, Bronchiolitis, Viral physiopathology, Bronchiolitis, Viral virology, COVID-19, Child, Child, Preschool, Coronavirus Infections physiopathology, Coronavirus Infections virology, Coronavirus NL63, Human, Coronavirus OC43, Human, Female, Fever physiopathology, Humans, Hypoxia physiopathology, Infant, Infant, Newborn, Influenza, Human epidemiology, Influenza, Human physiopathology, Influenza, Human virology, Male, Middle East Respiratory Syndrome Coronavirus, Pandemics, Picornaviridae Infections epidemiology, Picornaviridae Infections physiopathology, Picornaviridae Infections virology, Pneumonia, Viral physiopathology, Pneumonia, Viral virology, Prospective Studies, Respiratory Sounds physiopathology, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections physiopathology, Respiratory Syncytial Virus Infections virology, Respiratory Tract Infections epidemiology, Respiratory Tract Infections physiopathology, Respiratory Tract Infections virology, Rhinovirus, Severe acute respiratory syndrome-related coronavirus, SARS-CoV-2, Seasons, Severe Acute Respiratory Syndrome, Severity of Illness Index, Spain epidemiology, Bronchiolitis, Viral epidemiology, Coronavirus Infections epidemiology, Hospitalization, Pneumonia, Viral epidemiology
- Abstract
Background: Human coronaviruses (HCoVs) have been recognized as causative agents of respiratory tract infections.Our aim was to describe HCoV infections in hospitalized children in a prospective surveillance study for 14 years and compare them with other respiratory viruses., Methods: As a part of an ongoing prospective study to identify the etiology of viral respiratory infections in Spain, we performed the analysis of HCoV infections in children hospitalized in a secondary hospital in Madrid, between October 2005 and June 2018. Clinical data of HCoV patients were compared with those infected by rhinovirus, respiratory syncytial virus and influenza., Results: The study population consisted of 5131 hospitalizations for respiratory causes in children. A total of 3901 cases (75.9%) had a positive viral identification and 205 cases (4.1%) were positive for HCoV. Only 41 cases (20%) of HCoV infection were detected as single infections. Episodes of recurrent wheezing were the most common diagnosis, and 112 children (54%) had hypoxia. Clinical data in HCoV cases were similar to those associated with rhinovirus; however, patients with HCoV were younger. Other viruses were associated with hypoxia more frequently than cases with HCoV; high fever was more common in influenza infections and bronchiolitis in respiratory syncytial virus group. Although a slight peak of circulation appears mostly in winter, HCoV has been detected throughout the year as well., Conclusions: HCoV infections represent a small fraction of respiratory infections that require hospitalization in children and their characteristics do not differ greatly from other respiratory viral infections.
- Published
- 2020
- Full Text
- View/download PDF
40. [Massive cardiac lipomatosis, an autopsy finding in a patient with sudden death].
- Author
-
Zamarrón-de Lucas E, García-Fernández E, Carpio C, Alcolea S, Martínez-Abad Y, and Álvarez-Sala R
- Subjects
- Aged, Cardiomyopathies pathology, Fatal Outcome, Humans, Lipomatosis pathology, Male, Cardiomyopathies diagnosis, Death, Sudden, Cardiac etiology, Lipomatosis diagnosis
- Abstract
The fat replacement of myocardial cells is a degenerative process that usually affects the right ventricle and is found in 50% of the elderly. The problem arises when this degeneration occurs to a massive degree, a differential diagnosis with other pathologies being necessary. We present the case of a patient who died suddenly and a massive cardiac lipomatosis was found on autopsy, as the only explanation of the outcome., (Copyright © 2016 Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
41. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.
- Author
-
León X, Bothe C, García J, Parreño M, Alcolea S, Quer M, Vila L, and Camacho M
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell secondary, Carcinoma, Squamous Cell therapy, Cell Adhesion, Cell Line, Tumor, Disease-Free Survival, Endothelial Cells metabolism, Endothelial Cells pathology, Female, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms genetics, Head and Neck Neoplasms mortality, Head and Neck Neoplasms pathology, Head and Neck Neoplasms therapy, Humans, Interleukin-1alpha genetics, Male, Middle Aged, RNA Interference, RNA, Messenger genetics, RNA, Messenger metabolism, Risk Assessment, Risk Factors, Signal Transduction, Squamous Cell Carcinoma of Head and Neck, Time Factors, Transendothelial and Transepithelial Migration, Transfection, Treatment Outcome, Carcinoma, Squamous Cell metabolism, Cell Movement, Head and Neck Neoplasms metabolism, Interleukin-1alpha metabolism
- Abstract
The presence of IL-1 in human cancers is associated with aggressive tumor biology but its prognostic value is unknown. We studied whether IL-1α expression is a prognostic marker of distant metastasis in patients with head and neck squamous cell carcinoma (HNSCC). IL-1α mRNA and protein levels were determined in tumor samples and cancer cell lines using RT-PCR and ELISA. The effects of constitutive IL-1α expression by tumor lines were characterized. IL-1α mRNA and protein secretion were higher in tumor samples from patients who later developed distant metastasis than in patients who did not. By using distant metastasis as a dependent variable, patients were classified into two categories of IL-1α transcript-levels. The high-IL-1α group had a significantly lower five-year distant metastasis-free survival than the low-IL-1α group [70.0% (CI 95%: 55.9-84.1%) vs 94.7% (CI 95%:90.2-99.2%)]. When IL-1α transcript-levels were combined with clinical factors related to tumor metastasis, the predictive power of the model increased significantly. Additionally, transcript levels of IL-1α correlated significantly with those of the IL-1 family genes and genes related to the metastatic process. IL-1 treatment of microvascular endothelial cells increased adhesion of HNSCC cells but no differences were found based on constitutive IL-1α expression by tumor cells. Nevertheless, IL-1α produced by tumor cells effectively increased their transmigration across the endothelium. We found a significant relationship between IL-1α expression and development of distant metastasis in HNSCC patients. IL-1α expression could help to define a subset of patients at high risk of distant metastasis who could benefit from adjuvant treatment.
- Published
- 2015
- Full Text
- View/download PDF
42. Optical Coherence Tomography in Thromboembolic Pulmonary Hypertension.
- Author
-
Sánchez-Recalde Á, Alcolea S, and Ríos-Blanco JJ
- Subjects
- Humans, Hypertension, Pulmonary etiology, Pulmonary Embolism diagnosis, Hypertension, Pulmonary diagnosis, Pulmonary Embolism complications, Tomography, Optical Coherence methods
- Published
- 2015
- Full Text
- View/download PDF
43. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.
- Author
-
Camacho M, Piñeiro Z, Alcolea S, García J, Balart J, Terra X, Avilés-Jurado FX, Soler M, Quer M, León X, and Vila L
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell mortality, Cells, Cultured, Cyclooxygenase 2 metabolism, Female, Head and Neck Neoplasms mortality, Humans, Male, Middle Aged, Prognosis, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell radiotherapy, Cytochrome P-450 Enzyme System metabolism, Endothelium, Vascular metabolism, Head and Neck Neoplasms metabolism, Head and Neck Neoplasms radiotherapy, Intramolecular Oxidoreductases metabolism
- Abstract
Prostacyclin (PGI2 ) plays a role in cancer progression but the mechanism is currently poorly understood. Additionally, no data are available about the prognostic value of the PGI2 pathway in head and neck squamous cell carcinoma (HNSCC) therapy. We evaluated the expression of the PGI2 pathway in HNSCC patients. PGI2 production and PGI synthase (PGIS) expression, in terms of mRNA (RT-PCR) and protein (immunoblotting), were lower in tumour samples than in non-tumoural mucosa, whereas, as expected, COX-2 expression was increased in HNSCC tumour samples. Using local control of the tumour after radiotherapy or chemoradiotherapy as a dependent variable, patients were classified into two categories of PGIS transcript levels. The high-PGIS group had a significantly lower frequency of local and distant failure than the low-PGIS group, and the 5-year cancer-specific survival was higher [90.2% (95% CI 81.0-99.4%) versus 60.5% (95% CI 44.4-76.6%)]. None of the four HNSCC cell lines analysed expressed PGIS and therefore they did not produce PGI2 . However, HNSCC-conditioned media enhanced PGI2 production in endothelial cells (ECs). The stable analogue of PGI2 , carbaprostacyclin (cPGI2 ), exerted little effect on HNSCC cell line migration, and no effect on cell cycle distribution or proliferation rate after radiation injury was observed. Nevertheless, cPGI2 promoted EP-4-dependent in vitro angiogenesis. Von Willebrand factor expression (EC marker) and capillary density were significantly higher in the group of patients with high expression of PGIS. Our results indicate that PGIS expression was associated with radiotherapy efficiency. Although we do not provide direct evidence of a relationship between tumour vascularization and radiotherapy efficiency, our results suggest that the effect of PGI2 is related to its ability to promote vascularization. These results also support the concept that co-adjuvant therapy with PGIS enhancers, such as retinoids, could have therapeutic value for HNSCC treatment., (Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
44. Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm.
- Author
-
Camacho M, Dilmé J, Solà-Villà D, Rodríguez C, Bellmunt S, Siguero L, Alcolea S, Romero JM, Escudero JR, Martínez-González J, and Vila L
- Subjects
- Aged, Aorta, Abdominal pathology, Aorta, Abdominal physiopathology, Aortic Aneurysm, Abdominal immunology, Aortic Aneurysm, Abdominal pathology, Aortic Aneurysm, Abdominal physiopathology, Dinoprostone biosynthesis, Female, Gene Expression Regulation, Enzymologic, Humans, Leukocytes immunology, Male, Microvessels physiopathology, Middle Aged, Neovascularization, Pathologic, Prostaglandin-E Synthases, Aortic Aneurysm, Abdominal metabolism, Cyclooxygenase 2 metabolism, Intramolecular Oxidoreductases metabolism, Microvessels metabolism, Receptors, Prostaglandin E, EP4 Subtype metabolism
- Abstract
We investigated the prostaglandin (PG)E2 pathway in human abdominal aortic aneurysm (AAA) and its relationship with hypervascularization. We analyzed samples from patients undergoing AAA repair in comparison with those from healthy multiorgan donors. Patients were stratified according to maximum aortic diameter: low diameter (LD) (<55 mm), moderate diameter (MD) (55-69.9 mm), and high diameter (HD) (≥70 mm). AAA was characterized by abundant microvessels in the media and adventitia with perivascular infiltration of CD45-positive cells. Like endothelial cell markers, cyclooxygenase (COX)-2 and the microsomal isoform of prostaglandin E synthase (mPGES-1) transcripts were increased in AAA (4.4- and 1.4-fold, respectively). Both enzymes were localized in vascular cells and leukocytes, with maximal expression in the LD group, whereas leukocyte markers display a maximum in the MD group, suggesting that the upregulation of COX-2/mPGES-1 precedes maximal leukocyte infiltration. Plasma and in vitro tissue secreted levels of PGE2 metabolites were higher in AAA than in controls (plasma-controls, 19.9 ± 2.2; plasma-AAA, 38.8 ± 5.5 pg/ml; secretion-normal aorta, 16.5 ± 6.4; secretion-AAA, 72.9 ± 6.4 pg/mg; mean ± SEM). E-prostanoid receptor (EP)-2 and EP-4 were overexpressed in AAA, EP-4 being the only EP substantially expressed and colocalized with mPGES-1 in the microvasculature. Additionally, EP-4 mediated PGE2-induced angiogenesis in vitro. We provide new data concerning mPGES-1 expression in human AAA. Our findings suggest the potential relevance of the COX-2/mPGES-1/EP-4 axis in the AAA-associated hypervascularization.
- Published
- 2013
- Full Text
- View/download PDF
45. Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy.
- Author
-
Quintana A, Avilés FX, Terra X, Alcolea S, Camacho M, Quer M, Vila L, and León X
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell radiotherapy, Chemoradiotherapy, Female, Head and Neck Neoplasms radiotherapy, Humans, Male, Middle Aged, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local radiotherapy, Real-Time Polymerase Chain Reaction, Retrospective Studies, Squamous Cell Carcinoma of Head and Neck, Survival Rate, Carcinoma, Squamous Cell metabolism, Head and Neck Neoplasms metabolism, NF-kappa B metabolism, Neoplasm Recurrence, Local metabolism, RNA, Messenger metabolism
- Abstract
Background: The aim of this study was to evaluate nuclear factor-kappa B (NF-κB) expression as a biologic marker to predict local control in patients with head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy or chemoradiotherapy., Methods: The mRNA expression levels of the NF-κB family genes were determined with real-time-polymerase chain reaction in 77 patients with HNSCC treated with radiotherapy or chemoradiotherapy., Results: The mRNA NF-κB (p65) expression in pretreatment tumors was significantly related to local control (p = .03). The 5-year local recurrence-free survival rate in patients with low-level NF-κB (p65) expression (n = 42) was 79.9%, and in patients with a high level of expression it was 42.1% (p = .001). In a multivariate analysis, the mRNA NF-κB (p65) expression level was the only variable related to local control of the tumor., Conclusion: Expression of the NF-κB (p65) gene may be a radiosensitivity marker for patients with a HNSCC., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
46. Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk.
- Author
-
Camacho M, Martinez-Perez A, Buil A, Siguero L, Alcolea S, López S, Fontcuberta J, Souto JC, Vila L, and Soria JM
- Subjects
- 5-Lipoxygenase-Activating Proteins genetics, Adolescent, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases epidemiology, Child, Child, Preschool, Epoxide Hydrolases genetics, Female, Genetic Predisposition to Disease, Glutathione Transferase genetics, Humans, Leukotriene B4 blood, Male, Middle Aged, Phenotype, Risk Factors, Spain epidemiology, Arachidonate 5-Lipoxygenase genetics, Cardiovascular Diseases genetics, Thrombophilia genetics
- Abstract
Objective: Leukotrienes (LT) play a role in inflammation, cardiovascular diseases, and cancer. Although some studies suggest that there are genes that determine variability of some LT-related phenotypes, the genetic influence on these phenotypes has not been evaluated., Methods: The relative contributions of genetic and environmental influences to the 5-lipoxygenase pathway-related phenotypes (5-Lipoxygenase, five lipoxygenase activating protein (FLAP), LTA(4)-hydrolase and LTC(4)-synthase expression, and LTB(4)-plasma concentration and LTB(4) production by stimulated whole blood) were assessed in a sample of 934 individuals in 35 extended families. Our design is based on extended families recruited through a probands with idiopathic thrombophilia. This strategy allows us the analysis of the effects of measured covariates (such as sex, age and smoking), genes, and environmental variables shared by members of a household., Results: All of these phenotypes showed significant genetic contributions, with heritabilities ranging from 0.33 to 0.51 for enzyme expression and from 0.25 to 0.50 for LTB(4) production of the residual phenotypic variance. Significant phenotypic and genetic correlation among the LT-related traits was found. More importantly, FLAP and LTA(4)-hydrolase expression exhibit significant genetic correlations with arterial thrombosis, indicating that some of the genes that influence quantitative variation in these phenotypes also influence the risk of thrombosis., Conclusion: This is the first study that quantifies the genetic component of 5-Lipoxygenase pathway phenotypes. The high heritability of these traits and the significant genetic correlations between arterial thrombosis and some of these phenotypes suggest that the exploitation of correlated quantitative phenotypes will aid the search for susceptibility genes., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
47. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2.
- Author
-
Alcolea S, Antón R, Camacho M, Soler M, Alfranca A, Avilés-Jurado FX, Redondo JM, Quer M, León X, and Vila L
- Subjects
- Arachidonic Acid metabolism, Arachidonic Acid pharmacology, Carcinoma, Squamous Cell pathology, Cell Movement, Cell Proliferation, Chemical Fractionation, Coculture Techniques, Culture Media, Conditioned metabolism, Fibroblasts metabolism, Head and Neck Neoplasms pathology, Human Umbilical Vein Endothelial Cells, Humans, Imidazoles pharmacology, Interleukin-1 metabolism, Neovascularization, Pathologic metabolism, Neovascularization, Pathologic pathology, Prostaglandin-E Synthases, Prostaglandins F metabolism, Protein Array Analysis, Protein Stability, Pyridines pharmacology, Receptors, Interleukin-1 antagonists & inhibitors, Receptors, Interleukin-1 metabolism, Signal Transduction, Squamous Cell Carcinoma of Head and Neck, Tumor Cells, Cultured, Carcinoma, Squamous Cell metabolism, Cyclooxygenase 2 metabolism, Dinoprostone biosynthesis, Fibroblasts pathology, Head and Neck Neoplasms metabolism, Intramolecular Oxidoreductases metabolism
- Abstract
Prostaglandin (PG)E(2) is relevant in tumor biology, and interactions between tumor and stroma cells dramatically influence tumor progression. We tested the hypothesis that cross-talk between head and neck squamous cell carcinoma (HNSCC) cells and fibroblasts could substantially enhance PGE(2) biosynthesis. We observed an enhanced production of PGE(2) in cocultures of HNSCC cell lines and fibroblasts, which was consistent with an upregulation of COX-2 and microsomal PGE-synthase-1 (mPGES-1) in fibroblasts. In cultured endothelial cells, medium from fibroblasts treated with tumor cell-conditioned medium induced in vitro angiogenesis, and in tumor cell induced migration and proliferation, these effects were sensitive to PGs inhibition. Proteomic analysis shows that tumor cells released IL-1, and tumor cell-induced COX-2 and mPGES-1 were suppressed by the IL-1-receptor antagonist. IL-1α levels were higher than those of IL-1β in the tumor cell-conditioning medium and in the secretion from samples obtained from 20 patients with HNSCC. Fractionation of tumor cell-conditioning media indicated that tumor cells secreted mature and unprocessed forms of IL-1. Our results support the concept that tumor-associated fibroblasts are a relevant source of PGE(2) in the tumor mass. Because mPGES-1 seems to be essential for a substantial biosynthesis of PGE(2), these findings also strengthen the concept that mPGES-1 may be \a target for therapeutic intervention in patients with HNSCC.
- Published
- 2012
- Full Text
- View/download PDF
48. Hypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuli.
- Author
-
Camacho M, Rodríguez C, Guadall A, Alcolea S, Orriols M, Escudero JR, Martínez-González J, and Vila L
- Subjects
- Animals, Blotting, Western, Cell Hypoxia genetics, Cells, Cultured, Culture Media, Conditioned pharmacology, Cyclooxygenase 2 metabolism, Dinoprostone metabolism, Endothelial Cells drug effects, Endothelial Cells enzymology, Endothelial Cells metabolism, Humans, Male, Mice, Mice, Inbred C57BL, Myocytes, Smooth Muscle drug effects, Polymerase Chain Reaction, Promoter Regions, Genetic genetics, Prostaglandin-Endoperoxide Synthases genetics, Cell Hypoxia physiology, Epoprostenol metabolism, Interleukin-1beta pharmacology, Muscle, Smooth, Vascular cytology, Myocytes, Smooth Muscle enzymology, Myocytes, Smooth Muscle metabolism, Prostaglandin-Endoperoxide Synthases metabolism
- Abstract
Hypoxia affects vascular function and cell metabolism, survival, growth, and motility; these processes are partially regulated by prostanoids. We analyzed the effect of hypoxia and inflammation on key enzymes involved in prostanoid biosynthesis in human vascular cells. In human vascular smooth muscle cells (VSMC), hypoxia and interleukin (IL)-1β synergistically increased prostaglandin (PG)I₂ but not PGE₂ release, thereby increasing the PGI₂/PGE₂ ratio. Concomitantly, these stimuli upregulated cyclooxygenase-2 (COX-2) expression (mRNA and protein) and COX activity. Interestingly, hypoxia enhanced PGI-synthase (PGIS) expression and activity in VSMC and human endothelial cells. Hypoxia did not significantly modify the inducible microsomal-PGE-synthase (mPGES)-1. Hypoxia-inducible factor (HIF)-1α-silencing abrogated hypoxia-induced PGIS upregulation. PGIS transcriptional activity was enhanced by hypoxia; however, the minimal PGIS promoter responsive to hypoxia (-131 bp) did not contain any putative hypoxia response element (HRE), suggesting that HIF-1 does not directly drive PGIS transcription. Serial deletion and site-directed mutagenesis studies suggested several transcription factors participate cooperatively. Plasma levels of the stable metabolite of PGI₂ and PGIS expression in several tissues were also upregulated in mice exposed to hypoxia. These data suggest that PGIS upregulation is part of the adaptive response of vascular cells to hypoxic stress and could play a role in counteracting the deleterious effect of inflammatory stimuli.
- Published
- 2011
- Full Text
- View/download PDF
49. Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population.
- Author
-
Vila L, Martinez-Perez A, Camacho M, Buil A, Alcolea S, Pujol-Moix N, Soler M, Antón R, Souto JC, Fontcuberta J, and Soria JM
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Vessels enzymology, Child, Child, Preschool, Cyclooxygenase 1 genetics, Cyclooxygenase 1 metabolism, Cyclooxygenase 2 genetics, Cyclooxygenase 2 metabolism, Environment, Enzymes metabolism, Female, Gene Expression Regulation, Enzymologic, Humans, Intramolecular Oxidoreductases genetics, Intramolecular Oxidoreductases metabolism, Male, Middle Aged, Phenotype, Platelet Count, Prostaglandin-E Synthases, Spain, Thromboxane-A Synthase genetics, Thromboxane-A Synthase metabolism, Young Adult, Dinoprostone biosynthesis, Enzymes genetics, Thromboxane A2 biosynthesis, Vasculitis genetics, Vasculitis metabolism
- Abstract
Objective: Prostanoids play a critical role in clinical areas such as inflammation, thrombosis, immune response, and cancer. Although some studies suggest that there are genes that determine variability of some prostanoid-related phenotypes, the genetic influence on these traits has not been evaluated., Methods and Results: The relative contributions of genetic and environmental influences to the prostanoid biosynthetic pathway-related phenotypes, cyclooxygenase isoenzymes, microsomal-PGE-synthase-1 and TxA-synthase expression, and thromboxane-A(2) and prostaglandin-E(2) production by stimulated whole blood, were assessed in a sample of 308 individuals in 15 extended families. The effects of measured covariates (such as sex, age, and smoking), genes, and environmental variables shared by members of a household were quantified. Heritabilities ranging from 0.406 to 0.634 for enzyme expression and from 0.283 to 0. 751 for prostanoid production were found., Conclusions: These results demonstrate clearly the importance of genetic factors in determining variation in phenotypes that are components of the prostanoid biosynthetic pathways. The presence of such strong genetic effects suggest that it will be possible to localize previously unknown genes that influence quantitative variation in these phenotypes, some of which affect multiple aspects of cell biology, with important clinical implications.
- Published
- 2010
- Full Text
- View/download PDF
50. Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.
- Author
-
Brú A, Souto JC, Alcolea S, Antón R, Remacha A, Camacho M, Soler M, Brú I, Porres A, and Vila L
- Subjects
- Blotting, Western, Cell Adhesion physiology, Cell Line, Cell Line, Tumor, Cell Movement physiology, Chemokine CXCL1 metabolism, Flow Cytometry, HT29 Cells, Humans, Intercellular Adhesion Molecule-1 metabolism, Interleukin-8 metabolism, Neutrophils cytology, beta 2-Glycoprotein I metabolism, Cytokines metabolism, Neoplasms immunology, Neoplasms metabolism, Neutrophils immunology
- Abstract
There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines-colorectal adenocarcinoma (HT-29) and pharyngeal squamous-cell carcinoma (FaDu) cells-to act as inflammatory foci. PMNs were cytotoxic to both lines, the adhesion of the PMNs to the tumour cells being important in this effect. The tumour cells released appreciable amounts of IL-8 and GROalpha, and induced the transmigration of PMN through human microvascular-EC monolayers. Conditioning media associated with both lines induced the adhesion of PMN and the surface expression of ICAM-1 in microvascular-EC. In addition, FaDu-conditioning-medium strongly induced the production of proinflammatory cytokines by microvascular-EC. These results support the idea that tumour cells might normally induce a potent acute inflammatory response, leading to their own destruction.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.